Dr. Maureen D. Mayes, MD

Dr. Mayes practices at UT Physicians in Houston, Texas.

Dr. Mayes' NPI, 1255364238, was assigned on July 10, 2006. Dr. Mayes graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 1976. Dr. Mayes holds Texas license L4562.

Dr. Mayes' primary practice is UT Physicians, at 6410 Fannin St, Houston, TX 77030 in Harris County. The practice phone is (832) 325-7325.

Dr. Mayes' primary practice is UT Physicians in Houston, Texas. Dr. Mayes is also affiliated with Memorial Hermann-Texas Medical Center. The medical group on file is UT Physicians. Dmand AI also links Dr. Mayes to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mayes practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Mayes' primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Mayes is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Mayes' licenses on file in 5 states: Texas, Michigan, Virginia, West Virginia and Ohio.

Dmand AI lists muscle disease, muscle pain, fibromyalgia, and limb pain and rheumatoid arthritis among the conditions Dr. Mayes treats.

CMS data shows 139 Medicare services from Dr. Mayes across 3 procedure codes in 2024, for 73 Medicare patients. Medicare paid $9,721 for them. Every service was in an office.

CMS counts 73 Medicare patients who saw Dr. Mayes in 2024. The largest group is 65 to 74, with 39 patients. 74% of them have high blood pressure, and 70% have high cholesterol. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mayes' median patient age at 62, with 85% women.

In 2024, Dr. Mayes wrote 446 Medicare Part D claims for 58 patients. 93% of them were for generic drugs. CMS names the drug for 333 of them, across 12 drugs with 11 or more claims each, at $98,573 in total drug cost. In 2023, CMS named 352 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Mayes for performance year 2024, reported as part of a group. Dr. Mayes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mayes as offering telehealth.

Dmand AI links 288 papers to Dr. Mayes, published from 2005 to 2025. 2020 was the busiest year, with 16. The most frequent topics are Scleroderma, Systemic, Genetic Predisposition to Disease and Autoantibodies. Dr. Mayes has published most often in Arthritis Rheum. Dr. Mayes' most frequent co-authors are Shervin Assassi, MD, Daniel E. Furst, MD and John D. Reveille, MD.

Dmand AI links Dr. Mayes to 11 clinical trials, 4 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Scleroderma, Systemic, Scleroderma, Diffuse and Pulmonary Arterial Hypertension. National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most, 3. Open Payments lists research payments to Dr. Mayes that name 1 trial.

CMS Open Payments shows 242 general payments to Dr. Mayes from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Boehringer Ingelheim Pharma GmbH & Co.KG paid the most, $43,651. It also lists 3 research payments totaling $229 from 2017 to 2024, naming 1 clinical trial.

Dmand AI lists 4 awards for Dr. Mayes, most recently America's Top Doctors in 2020.

Dr. Mayes graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 1976. Dr. Mayes is a member of ACR and ACR.

Dr. Mayes is in network with 20 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.